Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Watercolour Stories – HCP Animation

We have been developing an approach to combine illustration with animation to create a 'living painting' that could be used to build and progress a story. Here are the results...

The Good Ideas Group

North – Corporate Animation

We partnered with 'North' to create a fun and vibrant launch animation. North are a business consultancy that bring fresh perspectives to running a business and they wanted their brand...

The Good Ideas Group

Cholangiocarcinoma – Disease Awareness

BackgroundCholangiocarcinoma (CCA) is a rare type of bile duct cancer, and it’s the second most common primary liver cancer in the world. Unfortunately, patients with CCA historically have limited treatment...

The Good Ideas Group

- PMLiVE

Merck’s Keytruda receives NICE recommendation as breast cancer treatment option

Patients will now be able to access immunotherapy at an earlier stage in their treatment journey

- PMLiVE

AstraZeneca’s Farxiga shows benefits for heart failure patients in phase 3 trial

The SGLT2 inhibitor improved symptom burden, physical limitations and quality of life

- PMLiVE

Eli Lilly set to launch Tempo Personalized Diabetes Management Platform

Users can use the app to log insulin doses, set reminders and access education resources

- PMLiVE

Creating the urgency and drive needed to tackle antimicrobial resistance

By Jamie Doggett

- PMLiVE

Pfizer’s multiple myeloma treatment granted FDA Breakthrough Therapy Designation

Elranatamab-treated patients achieved an overall response rate of 61% in a phase 2 trial

- PMLiVE

Lab-grown red blood cells used for human transfusions in world-first clinical trial

Manufactured blood cells could revolutionise treatments for people with blood disorders

- PMLiVE

Ionis reports positive phase 2b results for fesomersen in thrombosis prevention

The company also announced it will regain rights to the antisense medicine from Bayer

- PMLiVE

Sandoz to invest €50m in Austrian manufacturing facility to meet global antibiotic demand

Amoxicillin and other vital penicillin products will benefit from the investment

- PMLiVE

Boehringer and Lilly’s Jardiance shows promise in phase 3 chronic kidney disease trial

Jardiance reduced disease progression and cardiovascular death by 28%

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links